Low-intensity extracorporeal shockwave therapy among urologist practitioners: how the opinion of urologists changed between 2016 and 2019.
Journal
International journal of impotence research
ISSN: 1476-5489
Titre abrégé: Int J Impot Res
Pays: England
ID NLM: 9007383
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
03
05
2020
accepted:
13
08
2020
revised:
03
08
2020
pubmed:
23
8
2020
medline:
27
1
2022
entrez:
23
8
2020
Statut:
ppublish
Résumé
Over the past few years, an increase use of low-intensity shockwave therapy (LISWT) for the treatment of erectile dysfunction (ED) has been observed. However, many controversies in the scientific literature about its efficacy still exist. We aimed to investigate changes in the pattern of usage and attitudes toward LISWT for ED among experts over the last years. A dedicated online survey was sent to delegates at the Congress for the EAU Section of Andrological Urology (ESAU) in Prague from 31st October to 1st November 2019. The survey captured demographic data, professional background, and the experience and personal knowledge about LISWT. The results were compared with a previous survey conducted in 2016 and investigating the same topics in order to assess changes in the knowledge and opinion on LISWT over time. Overall, 172 and 192 questionnaires were available from 2019 and 2016, respectively. Participants in the 2019 survey were 80 (45.7%) urologists, 52 (29.7%) uro-andrologists, and 34 (19.4%) residents in urology, from 30 different countries. Compared to the past, we observed an increase of respondents who were familiar with LISWT (75 vs. 95%; p < 0.0001) and who performed LISWT in their routine practice (38% in 2019 vs. 14% in 2016; p < 0.0001). Conversely, no changes in terms of overall perception of treatment efficacy were registered over time (68% in 2019 vs. 72% in 2016 considered LISWT as an effective treatment, respectively (p = 0.5)). An increased proportion of physicians had suggested a wider application of LISWT, and some even advocated its use in nonvasculogenic ED (33% in 2019 vs. 5.9% in 2016; p < 0.0001). The awareness and clinical application of LISWT for ED have increased over time, despite the lack of robust evidence in terms of effectiveness. Further research on the benefit of LISWT is needed to guide physicians in the therapeutic management of ED patients.
Identifiants
pubmed: 32826969
doi: 10.1038/s41443-020-00347-x
pii: 10.1038/s41443-020-00347-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
839-843Investigateurs
Giorgio I Russo
(GI)
Paolo Capogrosso
(P)
Mikkel Fode
(M)
Maarten Albersen
(M)
Ahmet Urkmez
(A)
Georgios Hatzichristodoulou
(G)
Marco Falcone
(M)
Melianthe Nicolai
(M)
Murat Gul
(M)
Selkuk Sarikaya
(S)
Informations de copyright
© 2020. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Russo GI, di Mauro M, Cocci A, Cacciamani G, Cimino S, Serefoglu EC, et al. Consulting “Dr Google” for sexual dysfunction: a contemporary worldwide trend analysis. Int J Impot Res. 2019. https://doi.org/10.1038/s41443-019-0203-2 .
Towe M, El-Khatib F, Osman M, Huynh L, Carrion R, Ward S, et al. “Doc, if it were you, what would you do?”: a survey of Men’s Health specialists’ personal preferences regarding treatment modalities. Int J Impot Res. 2020. https://doi.org/10.1038/s41443-020-0263-3 .
Fode M, Lowenstein L, Reisman Y. Low-intensity extracorporeal shockwave therapy in sexual medicine: a questionnaire-based assessment of knowledge, clinical practice patterns, and attitudes in sexual medicine practitioners. Sex Med. 2017;5:e94–8.
doi: 10.1016/j.esxm.2016.12.002
Fode M, Hatzichristodoulou G, Serefoglu EC, Verze P, Albersen M. Low-intensity shockwave therapy for erectile dysfunction: is the evidence strong enough? Nat Rev Urol. 2017. https://doi.org/10.1038/nrurol.2017.119 .
Capogrosso P, Frey A, Jensen CFS, Rastrelli G, Russo GI, Torremade J, et al. Low-intensity shock wave therapy in sexual medicine-clinical recommendations from the European Society of Sexual Medicine (ESSM). J Sex Med. 2019;16:1490–505.
doi: 10.1016/j.jsxm.2019.07.016
Kim KS, Jeong HC, Choi SW, Choi YS, Cho HJ, Ha US, et al. Electromagnetic low-intensity extracorporeal shock wave therapy in patients with erectile dysfunction: a sham-controlled, double-blind, randomized prospective study. World J Mens Health. 2020;38:236–42.
doi: 10.5534/wjmh.190130
Sramkova T, Motil I, Jarkovsky J, Sramkova K. Erectile dysfunction treatment using focused linear low-intensity extracorporeal shockwaves: single-blind, sham-controlled, randomized clinical trial. Urol Int. 2019;104:1–8.
Yamaçake KGR, Carneiro F, Cury J, Lourenço R, Françolin PC, Piovesan AC, et al. Low-intensity shockwave therapy for erectile dysfunction in kidney transplant recipients. A prospective, randomized, double blinded, sham-controlled study with evaluation by penile Doppler ultrasonography. Int J Impot Res. 2018. https://doi.org/10.1038/s41443-018-0062-2 .
Baccaglini W, Pazeto CL, Corrêa Barros EA, Timóteo F, Monteiro L, Saad Rached RY, et al. The role of the low-intensity extracorporeal shockwave therapy on penile rehabilitation after radical prostatectomy: a randomized clinical trial. J Sex Med. 2020. https://doi.org/10.1016/j.jsxm.2019.12.024 .
Zewin TS, El-Assmy A, Harraz AM, Bazeed M, Shokeir AA, Sheir K, et al. Efficacy and safety of low-intensity shock wave therapy in penile rehabilitation post nerve-sparing radical cystoprostatectomy: a randomized controlled trial. Int Urol Nephrol. 2018;50:2007–14.
doi: 10.1007/s11255-018-1987-6
Clavijo RI, Kohn TP, Kohn JR, Ramasamy R. Effects of low-intensity extracorporeal shockwave therapy on erectile dysfunction: a systematic review and meta-analysis. J Sex Med. 2017;14:27–35.
doi: 10.1016/j.jsxm.2016.11.001
Sokolakis I, Hatzichristodoulou G. Clinical studies on low intensity extracorporeal shockwave therapy for erectile dysfunction: a systematic review and meta-analysis of randomised controlled trials. Int J Impot Res. 2019. https://doi.org/10.1038/s41443-019-0117-z .
Salonia A, Bettocchi C, Carvalho J, Corona G, Jones T, Kadioglu A, et al. EAU guidelines on sexual and reproductive health. Arnhem, The Netherlands: EAU Guidelines Office; 2020. http://uroweb.org/guidelines/compilations-of-all-guidelines/ .
Porst H, Burri A. Current strategies in the management of Peyronie’s disease (PD)—results of a survey of 401 sexual medicine experts across Europe. J Sex Med. 2019;16:901–8.
doi: 10.1016/j.jsxm.2019.03.404